Inclusion-body myositis associated with systemic sclerosis [5];Miositis con cuerpos de inclusión asociada a esclerosis sistémica

Medicina Clinica

Volumn 128, Issue 7, 2007, Pages 278-

  Bielsa, Silvia ^a   Madroñero, Ana Belén ^a   Grau, Josep Maria ^b   Porcel, Josẽ Manuel ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; LABORATORY DIAGNOSIS; LETTER; RAYNAUD PHENOMENON; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 33947512971     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(07)72561-7     Document Type: Letter

References (10)

1. Dalakas MC. Inflammatory, immune and viral aspects of inclusion-body myositis. Neurology. 2006;66 Suppl 1:33-8.
2. Schlesinger I, Soffer D, Lossos A, Meiner Z, Argov Z. Inclusion body myositis: atypical clinical presentations. Eur Neurol. 1996;36:89-93.
3. Hengstman GJD, Ter Laak HJ, Van Engelen BGM, Van Venrooij WS. Anti Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone. J Neurol Neurosurg Psychiatry. 2001;70:706.
4. Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Labrador-Horrillos M, Solans-Laqué R, Grau Junyent JM, Vilardell-Tarrés M. Anti-PM-Scl antibodies in a patient with inclusion body myositis. Rheumatology. 2003;42:1016-8.
5. Derk CT, Vivino FB, Kenyon L, Mandel S. Inclusion body myositis in connective tissue disorders: case report and review of the literature. Clin Rheumatol. 2003;22:324-8.
6. Auerbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 1992;49:1292-5.
7. Kusaoi M, Fakazawa T, Hirashima M, Morita Y, Yamaji C, Takai S, et al. A case of inclusion body myositis with systemic sclerosis. Mod Rheumatol. 2003;13:87-9.
8. Helm TN, Valenzuela R, Bergfeld WF, Guitart J, Poolos CJ. In vivo complement C3 binding to the intercellular substance and cytoplasm of epidermal basal cells in a patient with scleroderma and inclusion body myositis. J Am Acad Dermatol. 1990;23:753-4.
9. Salama J, Tome FM, Lebon P, Marie L, Delaporte P, Fardeau M. Myosite a inclusions. Étude clinique, morphologique et virologique concernant une nouvelle observation associée à une sclérodermie généralisée et à un syndrome de Klinefelter. Rev Neurol (Paris). 1980;136:863-78.
10. Kim S, Genth E, Krieg T, Hunzelmann N. Antikörper positive systemische Sklerodermie assoziiert mit Einschlusskörper-Myositis. Z Rheumatol. 2005;64:499-502.